GlassScriptPhysician profile
Curtis L Storm
NPI 1528301090
$13,042.74
in general payments reported to CMS, 2019-2025
51 companies · $1,644 in 2025
The $1,644 reported for 2025 was more than what 93% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,464 · 2020: $1,383 · 2021: $2,213 · 2022: $1,802 · 2023: $2,757 · 2024: $1,779 · 2025: $1,644.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,179.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $3,017.87 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Novo Nordisk INC | $2,153.83 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Abbvie INC. | $1,432.11 | 2021-2025 | Vraylar, Ubrelvy, Qulipta |
| Lilly USA, LLC | $1,008.87 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Pfizer INC. | $696.35 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $566.74 | 2019-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $453.54 | 2021-2025 | |
| Abbott Laboratories | $412.04 | 2021-2024 | Freestyle Libre 2, Freestyle Libre 3 |
| Amgen INC. | $329.02 | 2019-2025 | Evenity, Repatha, Otezla |
| Allergan, INC. | $302.23 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $215.72 | 2021-2024 | Onureg, Eliquis |
| Amarin Pharma, INC. | $214.21 | 2020-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $210.19 | 2019-2024 | Trintellix |
| Astellas Pharma US INC | $201.33 | 2020-2025 | Veozah, Myrbetriq |
| Intuitive Surgical, INC. | $180.69 | 2019-2023 | Da Vinci Surgical System |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Curtis Storm listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.